News

Monday, 29 October 2012 - 17:18

Last Tuesday, 23 October, MSF and TAC co-hosted a meeting to examine South Africa’s Intellectual Property Policy – currently under development by the Department of Trade and Industry (DTI) - from a public health perspective.

The meeting focused on how amending South Africa’s patent laws to include key flexibilities allowed under for international law could protect health and strengthen manufacture of generic drugs, including by local companies. Local and international experts outlined the current challenges posed by excessive pharmaceutical patenting and the limitations of the...

Read more
Saturday, 20 October 2012 - 08:22

Treatment Action Campaign has written a letter to the minister of health raising concerns about some specifications in the ARV tender. The inclusion of FDC’s in the tender is welcomed but TAC would like for price to not be the only deciding factor when choosing which regimens to procure. FDC’s have been proven to be beneficial for improved adherence to treatment. FDCs make prescribing, dispensing and monitoring treatment easier for nurses and pharmacists.

TAC urges the Department of Health to intervene in the ARV tender process to ensure that FDCs will be preferred over mono-...

Read more
Friday, 31 August 2012 - 10:19

Yesterday, TAC and HIV-911 Programme sent a joint letter to the Durban Business Fair and the Provincial and Ethekwini AIDS Councils, regarding the plans of Umlingo WamaNgcolosi Lifestyle to exhibit at the upcoming Durban Business Fair. The letter outlines the potential harm to public health of providing a platform to the organisation to spread misinformation about HIV/AIDS and its treatment. The full letter can be read here

Yesterday, TAC and HIV-911 Programme sent a joint letter to the...

Read more
Tuesday, 31 July 2012 - 09:31

TAC intervention leads to important legal advance: public interest concerns are relevant in determining interim interdict in patent cases

On 26 July 2012, the Supreme Court of Appeal handed down its judgment in the matter between the Aventis group of pharmaceutical companies and Cipla’s group of generic pharmaceutical companies.

TAC intervention leads to important legal advance: public interest concerns are relevant in determining interim interdict in patent cases

On 26 July 2012, the Supreme Court of Appeal handed down its judgment in the matter between the Aventis...

Read more
Tuesday, 12 June 2012 - 23:03

Statement by the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam

 
On 12 June 2012, The Treatment Action Campaign (TAC), SECTION27, Médecins Sans Frontières and Oxfam hosted a meeting prior to the launch of the 3rd SA TB Conference. The meeting brought together TB clinicians, counsellors, patients, activists and academics. Speakers and participants drew attention to the many challenges and failures of the country’s response to TB and DR TB, but also highlighted important...
Read more

Pages